Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.
Browse the full archive, newest first.
Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.
Strategic angle: Stevanato Group shows resilience in its core business amid significant market challenges.
Strategic angle: The Justice Department signals a shift in approach to antitrust enforcement under the Trump administration.
Strategic angle: Powerful blasts destroyed homes and sparked panic in the city of Bujumbura on Tuesday night.
Strategic angle: Governments are still at loggerheads over the timeline for publishing the Intergovernmental Panel on Climate... The post IPCC: ‘Frustrating and disappointing’ meeting leaves AR7 timeline in deadlock appeared first on Car
Strategic angle: This policy tracker documents exceptions in each state’s most restrictive gestational limit or total ban.
Strategic angle: Fed up with an increase in outages and surging fuel prices, a growing number of homes and businesses are ditching their backup generators for solar systems The post Nigerians bet on solar as global oil shock hits wallets
Strategic angle: Willie Peters urges his Hull KR players to harness their emotions for a strong finish as he prepares to depart.